Genomic partitioning of Alzheimer's disease in humans reveals non-CNS etiology
Cunha, C.; J. Romero-Lado, M.; Pielies Avelli, M.; Sanz Martinez, R.; R. Belanich, J.; R. Jones, T.; Claussnitzer, M.; J. F. Loos, R.; O. Kilpeläinen, T.
Show abstract
Alzheimers disease (AD) is marked by hallmark neuropathological changes in the brain. However, its upstream genetic determinants, beyond the central nervous system (CNS), remain largely unexplored. To that extent, we integrated human genomic data with cross-tissue and single-cell analyses across up to 40 peripheral tissues and 100 brain regions. We observed limited genetic enrichment in the CNS, with brain-resident microglia emerging as the sole enriched cell type. Instead, AD risk loci were predominantly enriched in peripheral immune compartments and immune-enriched barrier tissues, such as the lung and the digestive tract, and particularly within myeloid-lineage cells. Leveraging gene expression profiles from peripheral immune cells, we recreated an age-related susceptibility curve for AD, identifying ages 55-60 as a critical window for immune activation linked to AD risk. Our findings position the peripheral immune system as a central contributor of disease susceptibility, opening new directions for early intervention beyond the brain.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Spatial and single-nucleus transcriptomic analysis of genetic and sporadic forms of Alzheimer's Disease 98%
- Genetics of the human microglia regulome refines Alzheimer’s disease risk loci 98%
- Atlas of genetic effects in human microglia transcriptome across brain regions, aging and disease pathologies 98%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- The molecular impact of cigarette smoking resembles aging across tissues 94%
- Refining epigenetic prediction of chronological and biological age 92%
- Identification and drug-induced reversion of molecular signatures of Alzheimers disease onset and progression in AppNL-G-F, AppNL-F and 3xTg-AD mouse models 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.